KLF 5 strengthens drug resistance of ovarian cancer stem‐like cells by regulating survivin expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

KLF 5 strengthens drug resistance of ovarian cancer stem‐like cells by regulating survivin expression

Published:2013-07-21 Issue:4 Volume:46 Page:425-435
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Prolif.

Author:

Dong Z.¹,Yang L.¹,Lai D.¹

Affiliation:

1. The International Peace Maternity and Child Health Hospital School of Medicine Shanghai Jiaotong University Shanghai 200030 China

Funder

Key Project Fund of Shanghai Municipal Health Bureau

National Natural Science Foundation of China

Shanghai Municipal Health Bureau

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.12043

Reference38 articles.

1. Cancer of the Ovary

2. Treatment goals in ovarian cancer

3. Role of pegylated liposomal doxorubicin in ovarian cancer

4. Tumour stem cells and drug resistance

5. Cancer Stem Cells: Models and Concepts

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Insights into the Anticancer Activity of Withaferin-A: The Inhibition of Survivin Signaling;Cancers;2024-09-05

2. KLF5-mediated CDCA5 expression promotes tumor development and progression of epithelial ovarian carcinoma;Experimental Cell Research;2023-08

3. Single‐cell RNA‐sequencing analysis reveals divergent transcriptome events between platinum‐sensitive and platinum‐resistant high‐grade serous ovarian carcinoma;The Journal of Gene Medicine;2023-04-26

4. DANCR Induces Cisplatin Resistance of Triple-Negative Breast Cancer by KLF5/p27 Signaling;The American Journal of Pathology;2023-03

5. Protein acylation: mechanisms, biological functions and therapeutic targets;Signal Transduction and Targeted Therapy;2022-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3